Chen-Hua Liu

36PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - carbohydratesMetabolic medicineCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Feb 27, 2026
Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.

Yu-Ping Chang, Yun-Chu Chen, Chen-Hua Liu

|Jan 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng

|Jan 15, 2026
Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis.

Yu-Ping Chang, Yun-Chu Chen, Ji-Yuh Lee

|Jan 10, 2026
Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies.

Yu-Ping Chang, Yun-Chu Chen, Chen-Hua Liu

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

|Jun 20, 2025
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold.

Tai-Chung Tseng, Shang-Chin Huang, Mei-Hung Pan

Pageof 6

Frequent Collaborators

29 joint publications

Jia-Horng Kao

12 joint publications

Chun-Jen Liu

11 joint publications

Cheng-Yuan Peng

9 joint publications

Tung-Hung Su